Picture of PAION AG logo

PA8 — PAION AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Paion: Rr-Pharm starts phase III trial in general anesthesia

Aug 7 (Reuters) - PAION AG  PA8G.DE : 
    * DGAP-NEWS: PAION ANNOUNCES CLINICAL DEVELOPMENT PROGRESS WITH REMIMAZOLAM BY ITS PARTNER 
R-PHARM IN RUSSIA 
    * R-PHARM HAS STARTED A PHASE III TRIAL IN GENERAL ANESTHESIA 
    * REMIMAZOLAM ADMINISTERED TO FIRST PATIENT IN AUGUST 2017 
 
Source text for Eikon:  ID:nEQbNXwRSa  
Further company coverage:  PA8G.DE  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on PAION AG

See all news